Marine Novel Secondary Metabolites and Potential Immunomodulatory Properties
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Pharmacology".
Deadline for manuscript submissions: 30 April 2025 | Viewed by 35
Special Issue Editor
Interests: pharmaceutical; anti-cancer agents; immunomodulatory; natural products; signaling pathway
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue aims to explore the emerging field of marine novel secondary metabolites and their potential immunomodulatory properties. Marine organisms are a rich source of bioactive compounds that exhibit diverse pharmacological activities, including immunomodulation, which plays a critical role in human health and disease management. We invite researchers to contribute original research articles, reviews, and short communications that delve into the mechanisms of action, structural characterization, and therapeutic applications of these compounds. Topics of interest include, but are not limited to, the identification of novel secondary metabolites from marine sources, their immunomodulatory effects, and potential applications in the treatment of immune-related disorders. By highlighting recent advancements in this area, we aim to foster collaboration and innovation in marine biomedicine.
Dr. Ji-Hye Ahn
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine secondary metabolites
- immunomodulation
- bioactive compounds
- marine pharmacology
- immune response
- novel therapeutics
- antioxidant properties
- drug discovery
- natural products
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
